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Abstract
7KHVFLHQWLVWZKRGLVFRYHUHGSHQLFLOOLQDQGLWVXVHDVDQDQWLELRWLF$OH[DQGHU)OHPLQJDOVRUDLVHGFRQFHUQVDERXWEDFWHULDOUHVLVWDQFH$VKHSUHGLFWHGLQWKHWZHQW\ÀUVWFHQWXU\WKHRYHUZKHOPLQJXVHRIDQWLELRWLFVKDVOHGWRERWKGUXJDQGPXOWLGUXJUHVLVtant bacteria.This paper attempts to investigate the antibacterial potential of silver nanoparticles against drug resistant bacteria.
%\XVLQJ7RXUR·VRQOLQHOLEUDU\GDWDEDVHWKHHIÀFDF\RIVLOYHUQDQRSDUWLFOHVDVDSRWHQWLDODQWLEDFWHULDODJHQWZDVFRPSUHKHQVLYHO\
UHVHDUFKHG8VLQJWUDQVPLVVLRQHOHFWURQPLFURVFRS\DQGWKHGLVNGLIIXVLRQPHWKRGVLOYHUQDQRSDUWLFOHVKDYHEHHQIRXQGWRH[HUW
bactericidal effects by adsorbing to the cell surface and by entering the cell. The small size of the particles confers it with a high
surface area which thus enables the silver nanoparticles to effectively interact with the cell membrane and thereafter enter into
the cell. Moreover, the dose and shape of silver nanoparticles affects their antibacterial properties. While it has been found to
be dose dependent, there is controversy regarding which shaped particle, sphere or triangular, has the greatest ability to damage
WKHFHOOPHPEUDQH WUDQVSRUWV\VWHPV '1$ DQGSURWHLQV LQDGGLWLRQWRJHQHUDWLQJUHDFWLYHR[\JHQVSHFLHV 0RVWVWXGLHVKDYH
IRXQGWKHSDUWLFOHVWREHQRQWR[LFDWORZOHYHOVEXWVRPHXQFHUWDLQW\VWLOOH[LVWV,QDGGLWLRQVLOYHUQDQRSDUWLFOHVVHHPWRKDYHD
V\QHUJLVWLFHIIHFWZLWKWKHVLPXOWDQHRXVXVHRIDQWLELRWLFV)XUWKHUUHVHDUFKPXVWEHGRQHEHIRUHVLOYHUQDQRSDUWLFOHVFDQEHXVHG
as a new and effective antimicrobial agent.
Introduction and Background
On February 27th 2017, the World Health Organization
(WHO) published a list of the top twelve resistant bacteria that
greatly endanger human health (Press Association, 2017). Drug
resistant and multi-drug resistant bacteria are one of the most
serious public health threats the world faces today. Antibacterial
resistance is the ability of bacteria to survive even in the presence of antibiotics. The development of antibiotics has made a
JUHDWLPSDFWRQWKHPHGLFDOÀHOGE\HQDEOLQJGRFWRUVDQGKHDOWK
professionals to successfully combat many diseases. However,
with the rise of the use of antibiotics, drug resistance has
evolved, and according to WHO statistics, 700,000 people die
annually from infections and diseases that have resulted from
such resistant bacteria (Press Association, 2017).

Method
The research discussed in this paper was compiled from various published articles obtained from Touro’s online database
including Proquest as well as PubMed’s database to research
the actions of antibiotics, drug resistant bacteria, and the use of
silver nanoparticles against drug resistant bacteria.

A. Antibiotics and their mechanism of action
$QWLELRWLFVDUHQDWXUDORUV\QWKHWLFDJHQWVWKDWÀJKWDQGLQKLELW
the growth of bacteria. Antibiotics are grouped into different
classes based on their mechanism of action, and they can either
disrupt the cell membrane, or they can inhibit cell wall synthesis,
protein synthesis, DNA replication and repair, RNA synthesis,
or various metabolic pathways.

ZKLFKDLGLQWKHÀQDOVWHSVRIWKHFHOOZDOOV\QWKHVLVE\DGGLQJ
new peptidoglycan units to extend the sugar chain and by linking the amides of the peptide strands, respectively (Walsh, 2000).
Numerous antibiotics, like the B-lactam class of antibiotics, target
different steps in the synthesis of the peptidoglycan. Penicillins
and cephalosporins act as pseudo-substrates for the penicillin
binding proteins (PBPs), the active site of the transpeptidases, in
order to prevent the cross-linking of the PG. The cross-linking
action of the transpeptidases is responsible for the strength of
WKH3*DQGZLWKRXWLWWKHEDFWHULDOFHOOZDOOLVVLJQLÀFDQWO\ZHDNer and therefore more prone to lysis. When B-lactam antibiotics
bind to the PBPs, the oxygen from the serine residue located near
the PBP attacks the B-lactam ring and forms a penicilloyl-enzyme
complex. The serine is then acylated by the b-lactam which thus
inactivates transpeptidases (Walsh, 2000). Consequently, transpeptidases can no longer bind to the substrate, and therefore the
enzyme cannot complete the cross linking action (Andersson, et.
al. 2001) (Bockstael, Aerschot, 2009).
Vancomycin is a drug that belongs to the glycopeptide class of
antibiotics. Like the B-lactams, vancomycin targets the synthesis
of the cell wall. However, rather than targeting the enzymes
involved in the production of the PG, vancomycin targets the
VXEVWUDWHE\PDNLQJÀYHK\GURJHQERQGVZLWKWKH'DOD'DOD
terminus of each uncross-linked peptidoglycan (Lange et. al.
2007). By blocking the substrate of both the transpeptidases
and transglycosylases, vancomycin and other glycopeptides inhibit the cross linking of the peptidoglycan, resulting in a weaker
cell wall that is subject to osmotic lysis (Walsh, 2000)

2. Disruption of the Cell Membrane
1. Inhibition of Cell Wall Synthesis
Bacterial cell walls are comprised of peptidoglycan, the cytoplasmic
membrane, and in gram negative bacteria, the outer membrane.
The peptidoglycan, the strongest layer of the cell wall, is a netlike
arrangement of glycan and peptide strands. The biosynthesis of
the peptidoglycan is catalyzed by thirty different enzymes (Shah,
2015). Transglycosylases and transpeptidases are two enzymes

The cell membrane of bacterial cells are semipermeable membranes that are comprised of phospholipids, carbohydrates, and
proteins. Antibiotics like polymyxins and lipopeptides have the
ability to disrupt the bacterial cell membrane. Polymyxins like
colistin are cationic cyclic peptides that bind to the phospholipids in the bi-layer. By interacting with the negatively charged cell
membrane (Taneja, Kaur, 2016), colistin disrupts the bacterial cell

19

Aliza Eisig

membrane by displacing divalent ions, like calcium and magnesium, from the lipids present on surface of the cell.The disruption
of the cell membrane causes cell leakage and ultimately cell death
(Biswas, et. al, 2012) (Bockstael, Aerschot, 2009). Similarly, aminoglycosides can also displace these divalent ions to increase the
membrane’s permeability, resulting in the leakage of intracellular
content and cell death (Lange, et. al. 2007).
Furthermore, daptomycin, a lipopeptide, can also disrupt the
cell membrane. However, rather than displacing calcium and
magnesium ions, daptomycin forms pores in the membrane by
inserting its tail into the membrane. Consequently, there is a
SRWDVVLXPHIÁX[DQGDVSRWDVVLXPLRQVOHDYHWKHFHOOFHOOGHpolarization occurs (Shah, 2015) (Bockstael, Aerschot, 2009).
Besides for causing cell depolarization, daptomycin can also
inhibit the production of lipoteichoic acid which is responsible for regulating both cell division and cell shape (Bockstael,
Aerschot, 2009).

3. Inhibition of Protein Synthesis
In addition to targeting the synthesis of the cell wall and cell
membrane, other antibiotics exert their effects by inhibiting
bacterial protein synthesis. Ribosomes are essential to the synthesis of proteins as they translate the genes from mRNA into
proteins through the three steps of initiation, elongation, and
termination. The bacterial 70S ribosome has two subunits: the
50s subunit and the 30s subunit. While the large 50s subunit
contains a 5S rRNA, a 23S rRNA and 36 proteins, the smaller 30S subunit is comprised of 16S rRNA and 21 proteins.
Antibiotics can exert their effects by targeting either the 30S or
the 50S subunit (Bockstael, Aerschot, 2009).

Targeting the 30S Subunit
The 30S subunit contains the site where the codons are recognized by their corresponding tRNA anticodons. Transfer RNAs
help with the process of translation by acting at either the A site,
the P site, or the E site (Lange, et. al. 2007).
Aminoglycosides like gentamicin and tobramycin interact with
the 16s RNA located in the 30S subunit. By hydrogen bonding
with the substituents on the aminoglycoside cyclitol ring in the
16s RNA located at the A site, mistranslation occurs, and as a
result abnormal proteins are produced. These aberrant proteins
are then incorporated into the bacterial cell wall, ultimately resulting in a weak cell wall which is associated with cell leakage and
further penetration of the drug into the cell (Lange, et. al. 2007)
(Bockstael, Aerschot, 2009).
Tetracyclines bind to the 30s subunit (Lange, et. al. 2007) to
prevent the elongation step of protein synthesis. By blocking the
substrate of the incoming tRNAs, these antibiotics prevent new
amino acids from being added to the growing amino acid chain
(Shah, 2015).
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Targeting the 50S Subunit
While the antibiotics discussed above inhibit protein synthesis
via the 30S subunit, many other drugs have the ability to affect
protein synthesis through the 50S subunit. The 50S subunit is
associated with peptidyl transferase activity as well as the formation of peptide bonds (Bockstael, Aerschot, 2009).
Chloramphenicol, a broad spectrum antibiotic that is used
against both gram positive and negative bacteria, binds to the
23s RNA on the 50S subunit. This class of drugs inhibits the formation of peptide bonds by preventing the tRNAs from binding
to the A site (Bockstael, Aerschot, 2009).
The antibiotic class of macrolides binds to the 23S rRNA.
Consequently, the exit tunnel that helps transport the peptide
away from the peptidyl transferase center is blocked.
Lincosamides, like clindamycin, attack both the A site and P site
located in the peptidyl-transferase center (Lange, et. al.2007).
As a result, lincosamides inhibit the initiation of peptide chain
synthesis and detach tRNAs from the ribosome (Bockstael,
Aerschot, 2009).
Streptogramins affect protein synthesis and the action of the
peptidyl transferase center activity by binding to the 23S subunit
on the 50S ribosome. There are two types of streptogramins,
Type A and Type B. While type A prevents the step of elongation by blocking the substrate of the peptidyl-transferase center,
type B stimulates the premature release of incomplete peptide
bonds by inhibiting peptide bond synthesis (Bockstael, Aerschot,
2009).
Oxazolidinones act by targeting the 50S subunit. The drug
linezolid binds to the 23S subunit located on the 50S ribosome.
By binding to this subunit, the formation of the complex between tRNA, mRNA, and the ribosome is blocked which thus
LQKLELWVWKHIRUPDWLRQRIWKHÀUVWSHSWLGHERQG,IWKHFRPSOH[
is already formed, oxazolidinones can exert their effects by preventing the translocation of the peptidyl RNA from the A site to
the P site (Bockstael, Aerschot, 2009).

4. Inhibition of Metabolic Processes
Some antibiotics can interfere with various metabolic processes that are vital to the survival of bacteria. Folate and folic
acid are essential for the synthesis of purines, thymidines, and
some amino acids (Lange, et.al. 2007). The folic acid pathway
is catalyzed by dihydropteroate synthetase and dihydrofolate
reductase, two enzymes which aid in the production of 7, 8
dihydropteroate and tetrahydrofolate, respectively (Shledon Jr.,
2005). Drugs like sulphonamide and trimethoprim block different steps in this folic acid pathway, and while sulphonamide
competitively binds to p-aminobenozic acid in order to prevent
the actions of dihydropteroate synthetase, trimethoprim binds
to the enzyme dihydrofolate reductase to prevent the reduction
of dihydrofolic acid to tetrahydrofolic acid (Bockstael, Aerschot,
2009) (Sheldon Jr., 2005).
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5. Inhibition of DNA Replication

1. Enzymatic Degradation or Alteration

Topoisomerases I, II, III, and IV are enzymes that are essential
for DNA replication in bacterial species (Walsh, 2000). Bacterial
DNA is negatively supercoiled, and during DNA replication,
topoisomerase II, DNA gyrase, removes positive supercoils,
breaks the double bond, and decreases the linking number by
two. Furthermore, during DNA replication, topoisomerase IV
unlinks the daughter chromosomes (Bockstael, Aerschot, 2009).
Topoisomerases II and IV are vital for DNA topology, replication, and decatenation, and quinolone antibiotics target these
enzymes. By interacting with the complex formed between DNA
and DNA gyrase, quinolones make conformational changes that
affect the activity of both topoisomerases II and IV, and as a result,
DNA replication is blocked (Bockstael, Aerschot, 2009).
The process of transcription, the transferring of genes from
DNA to mRNA, is mediated by the multi-subunit enzyme RNA
polymerase. The antibiotic rifamycin targets DNA transcription
by binding to the beta subunit of RNA polymerase. Rifamycin
EORFNV WKH HQWU\ RI WKH ÀUVW QXFOHRWLGH WKHUHE\ EORFNLQJ WKH
action of RNA polymerase and inhibiting mRNA synthesis
(Bockstael, Aerschot, 2009).

Some bacterial species can resist a wide array of drugs by enzymatic degradation and alteration. By producing an enzyme that
destroys an antibiotic, bacterial species can cause various antibiotics to become ineffective. Antibiotics like penicillins, carbapenems, and cephalosporins all contain a B-lactam ring which binds
to PBPs on the peptidoglycan to prevent cross linkage of the
cell wall (James, 1999). In response, various bacteria produce
different classes of B-lactamases to hydrolyze the four membered B-lactam rings and thereby inactivate these antibiotics
(Sibanda, Okoh, 2007).
Similar to the B-lactamases, the aminoglycoside modifying
enzymes (AMEs) are enzymes that cause bacterial resistance to
aminoglycosides. Some microorganisms can produce enzymes
that modify drugs. Aminoglycosides like kanamycin, gentamicin,
streptomycin, and neomycin can either be acylated, adenylated,
or phosphorylated by aminoglycoside acetyltransferase, adenyltransferase, and phosphoryltransferase. Consequently, the modLÀHGDQWLELRWLFVFDQQRORQJHUH[HUWWKHLUDQWLEDFWHULDOHIIHFWV
(James, 1999) (Gabani, et. al 2012).

2. Alteration of Targets

)LJ3ULPDU\WDUJHWVVLWHIRUPDMRUFODVVHVRIDQWLPLFURELDODJHQWV

B. Mechanism of Resistance
5HVLVWDQFH FDQ EH FODVVLÀHG DV HLWKHU LQWULQVLF RU H[WULQVLF
,QWULQVLF UHVLVWDQFH LV UHVLVWDQFH WKDW LV LQKHUHQW WR D VSHFLÀF
species of bacteria. For example, the bacteria belonging to the
genus of Enterobacter, Klebsiella, and Escherichia coli are all resistant to methicillin, clindamycin, and vancomycin (James, 1999).
Various species of bacteria all differ in the variation of their
FHOOZDOOVHIÁX[SXPSVDQGELRÀOPVDOORIZKLFKOHQGVLWVHOIWR
different bacteria’s innate resistance to certain drugs (Sheldon
Jr., 2005).
Extrinsic or acquired resistance, on the other hand, arises
when bacteria acquire new resistance to numerous drugs via
different mechanisms. Resistant bacteria can degrade and modify
enzymes, alter the targets of antibiotics, change the permeability
of their cell wall, or alter metabolic pathways to prevent drugs
from penetrating and affecting their cells (Sheldon Jr., 2005).

In order to have a combative effect on bacteria, antibiotics must
bind to their intended receptors. Therefore, in response to variRXVDQWLELRWLFVEDFWHULDFDQUHGXFHWKHDIÀQLW\RIWKHDQWLELRWLFV
by modifying the structure of the drugs’ active site. Different bacterial species like methicillin-resistant Staphylococcus aureus and
Streptococcus pneumoniae produce new penicillin binding proteins, PBP2a and PBP2b respectively, in the presence of antibiotics.
7KHVH PRGLÀHG DFWLYH VLWHV KDYH D ORZHU DIÀQLW\ IRU %ODFWDPV
which, in turn, prevent the drugs from properly binding and having
an antibacterial effect (James, 1999). Furthermore, substituting at
OHDVWRQHDPLQRDFLGLQWKH3%3FDQUHVXOWLQDORZHUDIÀQLW\RIWKH
drug, and as a result the bacterial cell wall is not destroyed by the
antibiotic (Gabani, et. al. 2012) (Sibanda, Okoh, 2007).
In different species of bacteria, the N^6 amino group of an adenine
residue located in 23S rRNA is methylated, and as a result bacterial resistance to macrolides, lincosamides, and streptogramin
B arises. The mechanism behind this resistance is associated with
WKH UHGXFHG DIÀQLW\ RI WKH ELQGLQJ VLWHV WKDW UHVXOWV IURP FRQformational changes from the methylation (Sibanda, Okoh, 2007).

3. Alteration of Permeability
In addition to altering the targets of antibiotics, drug resistant
bacteria can modify the permeability of their cell wall in order
to prevent or decrease the entrance of various drugs into the
cell. A drug’s concentration in the bacterial cell determines the
HIÀFDF\ RI WKH GUXJ RQ WKH SDWKRJHQ DQG LW LV WKURXJK ERWK
SRULQV DQG HIÁX[ SXPSV WKDW GUXJ UHVLVWDQW EDFWHULD KDYH WKH
ability to decrease the amount of drug that reaches the cell
(Lange, et.al. 2007) (James, 1999) (Sheldon Jr., 2005).
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Porins
Porins are protein channels that exist solely in the outer membranes of gram negative bacteria. These channels are highly
VSHFLÀFDQGGHSHQGLQJRQVL]HVKDSHDQGFKDUJHFHUWDLQPROHcules can pass through to the inside of the cell. Being hydrophilic
molecules, antibiotics easily enter the cell through these protein
channels. Research has shown that when bacteria lose porins in
their outer membrane, drug resistance emerges since less of the
antibiotic can enter into the cell. For example, when the amount
of OPrD porins were decreased in Pseudomonas, the imipenem
class of antibiotics could not enter the bacterial cell. Similarly,
resistance to imipenem and meropenem occurred after the
amount of 29-kDa Porins was reduced in Acinetobacter baumannii. Multi-drug resistant bacteria like Klebsiella pneumoniae also display resistance to cephalosporins and carbapenems
after losing OmpK35 and OmpK36, outer membrane proteins
(Santajit, Indrawattana, 2016).

much research has been done to determine proper treatments
for such deadly infections. This paper will discuss the effectiveness of silver nanoparticles against drug resistant bacteria.

1. Silver Nanoparticles
Silver is widely known for its antimicrobial properties, and
therefore, silver nanoparticles (Ag NPs) have been widely
studied as a potential antibacterial agent against drug-resistant
bacteria. Various studies on different strains of bacteria were
performed to uncover the antibacterial effects of Ag NPs. More
VSHFLÀFDOO\WKHVWXGLHVIRFXVHGRQWKHVL]HGRVHDQGVKDSHRI
these silver particles coupled with the potential toxicity they
pose to human cells.
There are various methods to create nanoparticles. Ag NPs
can be synthesized into different shapes and sizes via physical
processes like laser ablation, evaporation, and condensation, or
through chemical processes like hydrazine, sodium borohydride,
and green synthesis (Nurani, et.al. 2015).

(IÁX[3XPSV
(IÁX[ SXPSV DFWLYHO\ WUDQVSRUW GUXJV RXW RI WKH EDFWHULDO FHOO
thereby decreasing the intracellular concentration of different
DQWLELRWLFV7KHUH DUH ÀYH GLIIHUHQW FDWHJRULHV RI HIÁX[ SXPSV
that exist in either gram positive or gram negative bacteria. The
ABC, RND, MFS, SMR, and Multidrug and toxic compound exWUXVLRQ IDPLO\ WUDQVSRUWHU HIÁX[ SXPSV DOO ELQG WR WKH GUXJ LQ
the phospholipid bilayer, and thereafter export it out of the cell
to different locations. While gram positive bacteria transporters
work by pumping the drug out of the cell across the cytoplasmic
PHPEUDQH JUDP QHJDWLYH HIÁX[ SXPSV FDQ HLWKHU H[WUXGH WKH
antibiotic across the membrane and into the periplasmic space, or
GLUHFWO\LQWRWKHH[WHUQDOPHGLXP$VWKHVHHIÁX[SXPSVTXLFNO\
extrude the antibiotics out, the concentration of antibiotics cannot accumulate to a high enough level to have an antibacterial
effect (Zgurskaya, 2002) (Lomovskaya, Watkins, 2001).

4. Altered Metabolic Pathway
Resistant bacteria have come up with alternate routes to obtain
metabolic products that are blocked by antibiotics.The folic acid
pathway produces pyridine thymidylate, an essential molecule in
the synthesis of DNA. In order to circumvent antibiotics that
target the folate pathway, Enterococcus either uses folinic acid
from its host cell, or mutates to have the ability to produce
thymine (Mambrio-Jones, Hoek, 2010) (Sheldon Jr., 2005).

Discussion:
C. Combating Drug Resistance
According to statistics, it is predicted that an estimated 10
million people will die from drug-resistant bacterial infections
by 2050 if no viable solution is discovered (Press Association,
 7KHUHIRUHÀQGLQJHIIHFWLYHWUHDWPHQWVIRUGUXJUHVLVWDQW
bacteria is of extreme importance. Over the last few years,
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1. Mode of Action of Silver Nanoparticles
After determining the bactericidal properties of silver nanoparticles, the mechanism behind their antimicrobial effects was
studied. Various studies using transmission electron microscopy
7(0 DQGRWKHUPHWKRGVYHULÀHGWKDW$J13VKDYHWKHDELOLW\WR
cause damage to bacterial cells through a wide array of different
mechanisms.
A Kirby-Bauer sensitivity test was performed, and by using various antibiotic discs with different silver resistant bacterial strains,
the zone of inhibition was measured. It was found that the bacWHULDVKRZHGPRGLÀHGVXVFHSWLELOLW\WRFHSKDORVSRULQVJO\FRSHSWLGHV DPLQRJO\FRVLGHV DQG ÁXRURTXLQRORQHV WKHUHE\ LQGLFDWLQJ
the mechanism of action of Ag NPs. Based on the action of these
antibiotics and the bacteria’s altered zone of inhibitions, this study
showed that these particles interact with the cell wall, proteins,
and DNA (Lara et. al. 2010).
Because of their small size, silver nanoparticles have the ability
to attach to the surface of the cell membrane and disrupt its
function. The positive charge of the Ag NPs allows them to electrostatically interact with the negatively charged membrane (Lara,
et.al. 2011). As transmission electron microscopy has shown with
E. coli cell membranes, silver nanoparticles disrupt the cell membrane, increase the cell’s permeability, and ultimately cause cell
death (Dakal, et. al. 2016) (Mambrio-Jones, Hoek, 2010).
)XUWKHUPRUHVLOYHUKDVDKLJKDIÀQLW\IRUVXOIXUDQGSKRVSKRrus (Nurani, et.al. 2015). Therefore, Ag NPs can also adsorb to
the cell membrane by interacting with thiol (SH) groups on the
cell membrane. As a result of this interaction, a new bond between sulfur and silver (S-Ag) is formed, and the creation of
this new bond blocks both respiration and the electron transfer. Ultimately, this results in the collapse of the proton motive
force. Without the proton motive force, the cell membrane
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is disrupted and cell leakage followed by cell death ensues
(Mijnendonckx, et. al. 2013).
Moreover, after weakening the cell membrane, these particles have the ability to penetrate the bacteria (Lara, et.al. 2010)
(Mijnendonckx, et.al. 2013). Additionally, in gram negative bacteria, porins help facilitate the entry of Ag NPs into the cell. Once
inside, these Ag NPs interact with various molecules resulting in
further cell damage (Dakal, et. al. 2016).
$J 13V KDYH D VLJQLÀFDQW HIIHFW RQ '1$ UHSOLFDWLRQ 6LOYHU
particles interact with thiol groups resulting in conformational
changes that ultimately inhibit the activity of various enzymes
(Mijnendonckx, et.al. 2013). Furthermore, when silver particles
bind to the guanine base, pyrimidine dimerization occurs, and
DNA replication is inhibited. Silver particles can also affect protein production and translation by interacting with and subsequently denaturing ribosomes (Dakal, et.al. 2016).
Moreover, silver nanoparticles are oxidized into silver ions
upon entering the bacterial cell. Ag ions cause damage and cell
death by interacting with lipids, proteins, and DNA. Silver ions
also interact with nucleosides in addition to forming complexes
with nucleic acids. Furthermore, these ions bind and dimerize
DNA and RNA, block the expression of proteins and enzymes
involved in ATP production, and generate free radicals (Lara,
et.al. 2010) (Mijnendonckx, et.al. 2013).
Reactive oxygen species can be endogenously produced from natural metabolic processes like aerobic respiration. Metal ions, like
silver, have the ability to catalyze the generation of free radicals
in the presence of oxygen (Mambrio-Jones,Hoek, 2010), and spin
resonance measurements have shown that silver ions increase
the production of reactive oxygen species (Mijnendonckx, et.al.
2013) (Mambrio-Jones, Hoek, 2010) (Kim, et. al. 2007). These free
radicals then act upon the mitochondrial membranes to induce
necrosis and cell death. Furthermore, ROS oxidize lipids, nucleic
acids, and proteins, thus disrupting the level of homeostasis by
inducing oxidative stress and cell damage.
In addition to increasing the production of ROS, silver particles
also decrease the levels of glutathione, an antioxidant, by reducing
LW LQWR JOXWDWKLRQH GLVXOÀGH 0RUHRYHU 13V LQKLELW WKH DFWLRQ RI
1$'3+GHSHQGHQWÁDYRHQ]\PHFDWDODVHJOXWDWKLRQHSHUR[LGDVH
and superoxide dismutase, anti-oxidative enzymes that quench free
radicals. These enzymes are dependent on thiol groups, but since
silver ions interact with thiol groups, these enzymes cannot properly quench the reactive oxygen species (Mijnendonckx, et.al. 2013)
(Dakal, et.al. 2016).
Phosphorylation and dephosphorylation are important signaling
processes in bacterial growth. Phosphorylated proteins guide DNA
replication and recombination, metabolism, and bacterial cell cycle.
Silver nanoparticles block this signaling pathway to prevent the
production and action of phosphorylated proteins. Furthermore,
phosphorylated tyrosine kinases aid in the transport of exopolysaccharide and capsular polysaccharides. Therefore, to prevent

bacterial growth, Ag NPs can also dephosphorylate these tyrosine
residues (Dakal, et. al. 2016) (Shirvastava, et.al. 2007).

Effects of Silver Nanoparticles on Gram Positive
and Gram Negative Bacteria
$JUHDWGHDORIFRQWURYHUV\H[LVWVUHJDUGLQJWKHHIÀFDF\RIVLOYHU
nanoparticles in both gram negative and gram positive bacteria.
In some studies, the Ag NPs had an equal effect in both types of
bacteria, rendering silver as a potential broad antibacterial agent
(Lara, et. al. 2010). However, other studies found that these particles are more effective in gram negative bacteria.This phenomenon is attributed to the differences in the composition of the
cell wall in both gram positive and gram negative bacteria. The
peptidoglycan in gram positive bacteria is very thick, averaging
around 20-80 nm, and rigidly cross linked. Because of this thick,
rigid membrane, there are fewer sites for the silver to adhere to,
making it harder for the particles to adsorb and penetrate the
cell. On the other hand, the cell wall of gram negative bacteria is
composed of a much thinner, roughly 7-8 nm, and weaker PG. In
addition, the membrane of gram negative bacteria contains the
lipopolysaccharide (LPS). Because of its negative charge, the LPS
increases the silver nanoparticles’ ability to successfully bind to
the cell’s surface. The thinner and weaker PG coupled with the
negatively charged LPS makes gram negative bacteria more susceptible to silver nanoparticles (Feng, et.al. 2000) (Shirvastava,
et.al. 2007) (Dakal. et.al. 2016).

2. Size of Silver Nanoparticles
3DUWLFOHVL]HVKDSHDQGGRVHDOOFRQWULEXWHWRWKHHIÀFDF\DQG
toxicity of silver particles. Extensive research has been done in
attempt to uncover the antibacterial effects of different sized
Ag NPs. Using the disk diffusion method, one study compared
WKH HIÀFDF\ RI GLIIHUHQW VL]HG QDQRSDUWLFOHV DJDLQVW ERWK JUDP
positive and gram negative bacteria. The relationship between
VL]HDQGHIÀFDF\RI$J13VKDVEHHQH[WHQVLYHO\UHVHDUFKHGDQG
it was concluded that the two are inversely related; the smaller the diameter of the particle, the more effective it is against
GUXJUHVLVWDQW EDFWHULD 7KH HIÀFDF\ RI VPDOOHU QDQRSDUWLFOHV
compared to larger NPs can be attributed to the relationship
between surface area and size. Surface area and particle size is
inversely related; the smaller the particles are, the larger their
surface area is (Rai, et. al. 2014). As a result of the increased
surface area, the smaller particles can interact with the bacterial
FHOOPRUHHIÀFLHQWO\ 5DLHWDO  +DLGHU.DQJ 

3. Dose of Silver Nanoparticles
After determining the mode of action of Ag NPs, researchers
began to study the dose required to have a bactericidal effect. By
using various doses, 0.0, 6.25, 12.5, 25.0, and 50.0 mM, against different strains of bacteria, it was found that dose and antibacterial
effect were directly related; the higher the dose of the Ag NPs,
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)LJXUH
'DNDOHWDO
1. 7KHPRGHRIDFWLRQRI$J13V
2. Adsorption to cell surface
3. Penetration into the cell to cause damage to various biomolecules
4. Generate ROS
5. Affect signaling processes

which contains numerous facets (Mambrio-Jones, Hoek, 2010)
(Raza, et.al. 2016) (Pal, et.al. 2007) (Mijnendonckx, et.al. 2013).
However, other research found contradictory results. Using
the disk diffusion method, the zone of inhibition of Pseudomonas
DHUXJLQRVD ZDV PHDVXUHG ZLWK WKH XVH RI ÀYH GLIIHUHQW VL]HG
and shaped particles: S1, S2, S3, S4, and S5, was measured. While
S1, S2, S3, S5 were all sphere shaped varying in size, S4 was
triangular shaped. After placing the particles in the center of
the sampled bacteria on an agar plate, the zone of inhibition of
S2, the smallest sphere particle, was 1.5 mm, while the zone of
inhibition for the triangular shaped particles was 1.4 mm. This
demonstrated that the smallest sphere particle had a greater
effect than the triangular shaped one (Raza, et.al. 2016). Using
x-ray diffraction, it was determined that the smaller spherical
shaped particles also contained high atomic density facets that
are found in triangular shaped Ag NPs which evidently contributed to the sphere’s greater bactericidal effect. Furthermore,
the sphere shaped Ag NPs acted as acids and interacted with
bases, sulfur and phosphorus containing compounds, to cause
damage to both the cell membrane and DNA (Raza, et.al. 2016).

5. Toxicity of Silver Nanoparticles

)LJXUH
0RURQHVHWDO
7(0DQDO\VLVRI
D %DFWHULDOFHOOVEHIRUHWUHDWPHQWRI$J13V
E F &HOOVDIWHUXVHRI$J13V
13VDWWDFKWRWKHVXUIDFHRIFHOODQGSHQHWUDWHLQVLGHWKHFHOO
the more effective they were.The highest dose, 50.0 mM, was the
most successful at killing bacteria (Lara, et.al. 2010). Furthermore,
the dose required to have a combative effect was found to be
EDFWHULDVSHFLÀFIRUHDFKJHQXV 0RURQHVHWDO 

4. Shape of Silver Nanoparticles
In addition to amount and size, shape also plays a role in the
HIÀFDF\RIWKHVLOYHUQDQRSDUWLFOHVDJDLQVWGUXJUHVLVWDQWEDFWHULD
)DFHWV DUH ÁDW VXUIDFHV WKDW DUH SUHVHQW RQ JHRPHWULF VKDSHV
Because of their large densities, facets have a higher surface
reactivity, and therefore Ag NPs with more {111} facets, facets
that are cut through the x, y, and z planes, have a greater effect
against bacteria (Mambrio-Jones, Hoek, 2010). Some research has
shown that triangular shaped particles are more effective than
both sphere and rod shaped particles at combating drug resistant
bacteria. The increased surface area and antibacterial effect of
triangle shaped particles can be due to their geometric structure
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The toxicity of any antimicrobial agent is a major issue of concern, and despite silver particles’ potential to act as an antimicrobial agent, at certain levels, silver nanoparticles can be toxic
to all mammals, including humans. Research has shown that Ag
NPs stimulate an immune response and induce apoptosis via the
JNK and ROS signaling pathways. As indicated by the levels of
glutathione, silver particles induce oxidative stress by decreasing the amount of the glutathione in the body. Additionally, due
to their high surface area, Ag NPs can also generate free radicals
from the respiratory chain. This imbalance between ROS and
antioxidant levels results in damage to both lipids and proteins
(Arora et.al. 2008) (Mambrio-Jones, Hoek, 2010). Silver NPs
also interact with the mitochondria to increase oxidative stress
and to disrupt ATP production, ultimately causing damage to
DNA. Ag NPs also affects protein folding. This increased stress
in the cell leads to cytotoxicity and apoptosis. Furthermore, Ag
NPs can enter the nucleus and induce genotoxicity by causing
DNA mutations, base damages, and strand breaks. Finally, these
particles induce carcinogenesis by activating different signaling
FDVFDGHVDQGLQÁDPPDWRU\UHVSRQVHV 'DNDOHWDO 
In a few studies, it was found that the dose of Ag NPs needed
to induce apoptosis was different from the dose required to stimulate necrosis, 0.78-1.56 vs. 12.5 μg. Therefore, it was concluded
that a safe dosing range of silver can be determined (MambrioJones, Hoek, 2010). However, a contradictory conclusion was
reached by AshaRani et. al who found silver nanoparticles can be
toxic to humans at any dose (AshaRani et.al. 2009) (MambrioJones, Hoek, 2010). Therefore, due to this discrepancy, further
research in regards to the toxicity of Ag NPs must be conducted.

Silver Nanoparticles and Drug Resistant Bacteria

6. Resistance to Silver Nanoparticles
As is the case with antibiotics, bacterial resistance to silver is a
major concern. When bacteria are exposed to silver nanoparticles, it results in the natural selection of bacteria, thus causing
bacterial resistance to silver particles.
Bacterial resistance to silver NPs can be encoded in the plasmid or in the chromosome as it is seen in both Salmonella and E.
coli respectively (Mambrio-Jones, Hoek, 2010). In Salmonella, the
resistance to silver ions is attributed to nine genes on the plasmid.
Furthermore, resistance is also associated with the SilCBA and
6LO3HIÁX[SXPSVWKH6LO(DQG6LO)SHULSODVPLFELQGLQJSURWHLQV
and in Escherichia coli porin loss. However, resistance to silver
nanoparticles as a result of a one point mutation is not very common because of the complexity of silver’s actions (Chopra, 2007).
Additionally, since silver nanoparticles have a high surface area,
they can aggregate and combine together, causing them to lose
their antibacterial effect (Nurani, et.al. 2015) (Beyth, et.al. 2015).
Furthermore, because of its high surface energy, Ag NPs can become contaminated by the air, and therefore Ag NPs are synthesized with either chitosan, alginate, or gelatin, biodegradable
polymer matrixes, to prevent their oxidation (Nurani, et.al. 2015).

7. Combination of antibiotics and AG NPs
The synergy of two drugs or compounds has the potential to
successfully combat drug-resistant bacteria by acting through
different mechanisms. Therefore, after determining the bactericidal effect of silver nanoparticles, many researchers attempted
to determine the effects of the use of Ag NPs in conjunction
with the use of antibiotics against different strains of bacteria.
To determine the synergy of Ag NPs with drugs, silver particles
were used with amoxicillin against samples of E. coli. By comparing the minimum inhibitory concentration of various doses
of silver nanoparticles alone, the use of different amounts of
amoxicillin by itself, in addition to the combined effects of both
silver NPs and amoxicillin, the advantages of combination therDS\ZDVLGHQWLÀHG
The combined effect of amoxicillin and Ag NPs was seen
to have a greater bactericidal effect than each of them alone.
Furthermore, when the two were administered together, a lower
dose of both amoxicillin and silver nanoparticles were needed to
stimulate an antibacterial effect as opposed to when each one
was given alone (Allahverdiyev, et. al. 2011) (Li, et. al 2005).
The success for this synergy can be attributed to a few different theories. With combination therapy, the two compounds or
drugs that are used usually target different steps, pathways, or
enzymes. Therefore, if bacteria resist the action of one antibiotic, the other compound can still exert its antimicrobial effects
through a different non-resistant mechanism.
Additionally, in non-resistant bacteria, the synergy of the two
can be attributed to the chelation reaction that occurs between
both the hydroxy and amino groups of the B-lactam and the Ag

NPs. The binding between the silver and the amoxicillin in addition to the binding between the antibiotic with other drug particles resulted in the formation of a new compound. This newly
synthesized antimicrobial agent, containing silver on the inside
and amoxicillin on the outside, attaches to the surface of the cell
membrane and causes more damage because of the synergy of
the two compounds. Additionally, the amoxicillin disrupted the
cell wall which increased the penetration of the Ag NPs into the
cell. Moreover, from this chelation reaction, silver nanoparticles
prevent DNA from unwinding, thus resulting in further damage
to bacterial DNA (Li, et. al. 2005) (Allahverdiyev, et. al. 2011).
Furthermore, silver nanoparticles can be used as a drug carrier. While antibiotics are usually hydrophilic, silver nanoparticles
are hydrophobic. Therefore, these nanoparticles can interact
with the hydrophobic bacterial cell membrane more easily than
antibiotics, enabling the transport of hydrophilic antibiotics to
the bacterial cell surface (Li, et. al. 2005).

)LJXUH
/LHWDO
The formation of a new antimicrobial agent through the chelation
UHDFWLRQEHWZHHQDPR[LFLOOLQDQGVLOYHUQDQRSDUWLFOHV

)LJXUH
$OODKYHUGL\HYHWDO
The mechanism of action of the combination of B-lactam antibiotics
ZLWKVLOYHUQDQRSDUWLFOHVLVVKRZQ7KHQHZO\IRUPHGDQWLEDFWHULDO
DJHQWLQWHUDFWVZLWKDQGGHVWUR\VWKHVXUIDFHRIWKHFHOO7KH$J13V
DOVRSUHYHQW'1$IURPXQZLQGLQJ

Conclusions
This paper attempted to explain the mechanism of action and
mechanism of resistance of antibiotics and drug resistant bacteria, respectively.As antibiotic resistance continues to emerge, researchers are constantly searching for new antimicrobial agents.
Silver nanoparticles have gained much attention as a possible
tool in combating drug resistant bacteria, and studies have provHQWKHHIÀFDF\RI$J13VWRLQGXFHFHOOGDPDJHDQGFHOOGHDWK
However, despite the growing potential of silver nanoparticles,
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further research must be conducted before implementing silver
nanoparticles into clinical trials as a promising way of replacing
or supplementing the currently used antibiotics.
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